Unlock the potential of Lithium testing

Product availability may vary by country; please confirm with your local representative.
Lithium (Eskalith, Lithobid) is the most widely used and recommended standard long-term treatment for Bi-Polar disorder, and one of the most consistently effective medicines in psychiatry. In 2021 approx.
50 million people were diagnosed with bi-polar disorder and on average 50% are treated with Lithium and tested regularly (2-4 times per year) due to a relatively narrow therapeutic range and toxicity.
The prevalence of bipolar disorder and growing awareness of therapeutic drug monitoring have driven significant growth in lithium testing.
Significant competitive advantages. Our new Lithium reagent offers cost-efficient testing alternative for the smaller and mid-sized laboratories
and tackles the hurdles of some of the Lithium testing methods.
Laboratory Costs tackled by VitalScientific Lithium reagent:
ISE (Ion-Selective Electrodes):
- Cost of Lithium electrode
- Shelf life of Lithium electrode
- Maintenance costs
- Specialized equipment and trained staff
AAS/FP standalone systems
- Special equipment and staff
- Additional maintenance costs
- Sample splitting results in inefficiencies and productivity loss
The VitalScientific Lithium reagent is a product of well proven technology,
carefully manufactured in our state-of-the-art, CE-IVDR and ISO 13485:2016
compliant facility in France, Europe.